Vanguard Personalized Indexing Management, LLC Mersana Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 36,692 shares of MRSN stock, worth $345,271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,692
Previous 42,638
13.95%
Holding current value
$345,271
Previous $14,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MRSN
# of Institutions
81Shares Held
93.6MCall Options Held
34.3KPut Options Held
14K-
Nextech Invest Ag12.1MShares$114 Million3.22% of portfolio
-
Nextech Invest, Ltd. Zurich, V812.1MShares$114 Million0.68% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$81.5 Million0.78% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$78.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$72.3 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $914M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...